+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Blood Screening - Global Market Trajectory & Analytics

  • PDF Icon


  • 382 Pages
  • April 2021
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 4804718
Global Blood Screening Market to Reach $4 Billion by 2027

Amid the COVID-19 crisis, the global market for Blood Screening estimated at US$2.3 Billion in the year 2020, is projected to reach a revised size of US$4 Billion by 2027, growing at a CAGR of 8.4% over the analysis period 2020-2027. Nucleic Acid Test (NAT), one of the segments analyzed in the report, is projected to record a 8.4% CAGR and reach US$1.8 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Enzyme-Linked Immunosorbent Assay (ELISA) segment is readjusted to a revised 8.3% CAGR for the next 7-year period.

The U.S. Market is Estimated at $611.3 Million, While China is Forecast to Grow at 12.7% CAGR

The Blood Screening market in the U.S. is estimated at US$611.3 Million in the year 2020. China, the world's second largest economy, is forecast to reach a projected market size of US$910.3 Million by the year 2027 trailing a CAGR of 12.6% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.6% and 7.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 5.5% CAGR.

Rapid Tests Segment to Record 9% CAGR

In the global Rapid Tests segment, USA, Canada, Japan, China and Europe will drive the 8.4% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$256 Million in the year 2020 will reach a projected size of US$449.1 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$554.3 Million by the year 2027, while Latin America will expand at a 10.6% CAGR through the analysis period.

Select Competitors (Total 46 Featured):
  • Abbott Laboratories
  • Beckman Coulter, Inc.
  • Becton, Dickinson & Company
  • bioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • F. Hoffmann-La Roche AG
  • Grifols International SA
  • Ortho Clinical Diagnostics, Inc.
  • Siemens Healthineers
  • Thermo Fisher Scientific, Inc.
Frequently Asked Questions about the Global Market for Blood Screening

What is the estimated value of the Global Market for Blood Screening?

The Global Market for Blood Screening was estimated to be valued at $2.3 Billion in 2020.

What is the growth rate of the Global Market for Blood Screening?

The growth rate of the Global Market for Blood Screening is 8.2%, with an estimated value of $4 Billion by 2027.

What is the forecasted size of the Global Market for Blood Screening?

The Global Market for Blood Screening is estimated to be worth $4 Billion by 2027.

Table of Contents


  • Influencer Market Insights
  • World Market Trajectories
  • Blood Screening Market to Witness Moderate Growth
  • The Nucleic Acid Test (NAT) Segment to Register Highest Growth
  • Impact of Covid-19 and a Looming Global Recession
  • Increase in Blood Donation Rates to Bode Well for Market Growth
  • Exhibit 1: Percentage of People Preferring to Donate Blood by Select Countries: 2018
  • Various Initiatives to Donate Blood Propel Market Growth
  • Rising Incidence of Infectious Diseases
  • Exhibit 2: Total Number of Disease Cases Reported in the US due to Infected Fleas, Ticks, and Mosquitoes: 2004-2016
  • Exhibit 3: Disease Response Towards Climate Change during the Recent Past
  • Opportunities and Challenges in Blood Screening
  • Innovations to Propel Market Growth
  • Various Measures for Ensuring Donated Blood Safety, a Key Driver for Market Growth
  • Introduction of Novel Products to Support Market Growth


  • Total Companies Profiled: 46